Literature DB >> 25170065

Characterisation of uveitis in association with multiple sclerosis.

Wyatt Messenger1, Lena Hildebrandt2, Friederike Mackensen2, Eric Suhler1, Matthias Becker3, James T Rosenbaum4.   

Abstract

PURPOSE: To characterise uveitis in association with multiple sclerosis (MS).
METHODS: We conducted a retrospective chart review of patients with uveitis and MS at two uveitis centres (Portland, Oregon, USA and Heidelberg, Germany). Baseline characteristics and ophthalmic data were collected at the patient's first and last visits. Additionally, neurological records were obtained when possible.
RESULTS: We identified 113 patients (196 eyes) with uveitis and MS. Of these, 53 had a diagnosis of MS confirmed by review of neurological records, 50 additional patients fulfilled the Poser criteria for MS and 10 with MS were referred by an outside neurologist. Among them, 83 (73%) were women and the mean age of presentation was 40.6 years (range 13-64 years). The average visual acuity in affected eyes at presentation was 20/39. There were 90 patients (80%) who presented with intermediate uveitis and 24 patients (15%) with anterior uveitis. Posterior and pan-uveitis were found in four patients (3%) and two patients (2%), respectively. During a median follow-up of 3.2 years (range 0.04-21 years), visual acuity improved -0.09 logMar/year. Compared with our location-matched controls with idiopathic intermediate uveitis (n=16), patients with MS and intermediate uveitis were significantly older when diagnosed with uveitis (p=0.027) and more likely to be female (p=0.01). There was no statistical difference in visual acuity or rate of vision change between our cases and controls (p=0.58 and p=0.36, respectively).
CONCLUSIONS: Uveitis with MS generally presents as intermediate uveitis with a minority presenting with anterior uveitis. Patients are significantly older and more likely to be women than patients with idiopathic intermediate uveitis. The visual prognosis is generally favourable. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Epidemiology; Inflammation

Mesh:

Year:  2014        PMID: 25170065     DOI: 10.1136/bjophthalmol-2014-305518

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Multiple Sclerosis and Panuveitis: A Rare Association.

Authors:  Burcu Gökçe Çokal; H Nalan Güneş; Selda Keskin Güler; Tahir Kurtuluş Yoldaş; Caner Baydar; Sevim Kavuncu
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

Review 2.  The Eyes Have it: A Rheumatologist's View of Uveitis.

Authors:  James T Rosenbaum; Andrew D Dick
Journal:  Arthritis Rheumatol       Date:  2018-08-23       Impact factor: 10.995

3.  Alemtuzumab-induced remission of multiple sclerosis-associated uveitis.

Authors:  Mark D Willis; Trevor P Pickersgill; Neil P Robertson; Richard W J Lee; Andrew D Dick; Ester Carreño
Journal:  Int Ophthalmol       Date:  2016-10-11       Impact factor: 2.031

4.  [Intraocular inflammation in multiple sclerosis].

Authors:  N Stübiger; K Ruprecht; U Pleyer
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

5.  Pattern ERGs suggest a possible retinal contribution to the visual acuity loss in acute optic neuritis.

Authors:  G T Plant; G E Holder; I Kleerekooper; L Del Porto; L Dell'Arti; J Guajardo; S Leo; A G Robson; S A Trip; A Petzold
Journal:  Doc Ophthalmol       Date:  2022-09-26       Impact factor: 1.854

6.  The Role of Fungi in the Etiology of Multiple Sclerosis.

Authors:  Julián Benito-León; Martin Laurence
Journal:  Front Neurol       Date:  2017-10-16       Impact factor: 4.003

7.  Spondyloarthritis, Acute Anterior Uveitis, and Fungi: Updating the Catterall-King Hypothesis.

Authors:  Martin Laurence; Mark Asquith; James T Rosenbaum
Journal:  Front Med (Lausanne)       Date:  2018-04-05

8.  Intermediate uveitis: pattern of etiology, complications, treatment and outcome in a tertiary academic center.

Authors:  Thomas Ness; Daniel Boehringer; Sonja Heinzelmann
Journal:  Orphanet J Rare Dis       Date:  2017-04-27       Impact factor: 4.123

9.  Objective quantification of vitreous haze on optical coherence tomography scans: no evidence for relationship between uveitis and inflammation in multiple sclerosis.

Authors:  D Coric; G Ometto; G Montesano; P A Keane; L J Balk; B M J Uitdehaag; A Petzold; D P Crabb; A K Denniston
Journal:  Eur J Neurol       Date:  2019-08-18       Impact factor: 6.089

Review 10.  Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system.

Authors:  Elsa How Shing Koy; Pierre Labauge; Athan Baillet; Clément Prati; Hubert Marotte; Yves-Marie Pers
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-07-09       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.